SkinBioTherapeutics chief "really pleased" with human trial data for new skin cream

03:21 EDT 8 Apr 2019 | Proactive Investors

“It is very difficult to change a healthy barrier and therefore the data showing improvement in some age groups gives us confidence in our partner discussions, and in seeking to develop future applications in disease conditions where the barrier is known to be poor such as eczema,” Dr Cath O’Neill said.

More From BioPortfolio on "SkinBioTherapeutics chief "really pleased" with human trial data for new skin cream"